Skip to main content
. 2021 Oct 14;12:741671. doi: 10.3389/fphar.2021.741671

TABLE 4.

Generalized linear regression model on unit price of all procured cardiovascular medicines with difference-in-differences analyses.

Variables β coefficient Robust product clustered standard error z p>|z| 95% confidence interval
Intervention effect (difference-in-differences) −0.45 0.16 −2.73 0.006 −0.77 to -0.13
Generic competition (X1) 0.17 0.20 0.87 0.385 −0.22 to 0.57
(X1)2 −0.02 0.02 −0.63 0.526 −0.06 to 0.03
Therapeutic competition (X2) −0.38 0.13 −3.03 0.002 −0.63 to -0.13
(X2)2 0.01 0.01 1.35 0.176 −0.00 to 0.02
Goodness-of-fit tests
Akaike Information Criterion (AIC) = 10.67
Bayesian Information Criterion (BIC) = -79,081.63

Note: Bold values indicate regression coefficients with statistical significance (p < 0.05).